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Keywords: b-lactamases, carbapenems, Enterobacter cloacae *Correspondence address. Service de Bactériologie, Hôpital Tenon, 4 rue de la Chine, 75970 Paris Cedex 20, France. Tel: þ33-1-56-01-70-18; E-mail: guillaume.arlet@tnn.aphp.fr Sir, Among b-lactam antibiotics, carbapenems are those that have the highest stability towards the hydrolytic activity of most of the innate natural and acquired extended-spectrum b-lactamases prevalent within bacterial species involved in clinical practice. However, emergence of acquired carbapenem-hydrolysing b-lactamases, i.e. carbapenemases, which were first recognized in the early 1990s in some isolates of opportunistic Gram-negative bacilli, has been increasingly reported from various parts of the world during the last decade. 1 Carbapenem-hydrolysing b-lactamases can be metallo-b-lactamases, expanded-spectrum oxacillinases or Ambler class A enzymes. 1,2 KPC b-lactamases are class A carbapenemases, which were first detected in 2001 in a Klebsiella pneumoniae isolate from North Carolina. 3 Soon afterwards, several reports documented the emergence of Enterobacteriaceae strains from various species producing KPC-2 and KPC-3 b-lactamase variants in the eastern USA and recently disseminated in other countries worldwide, such as France, Columbia, Israel and China. 2 A 31-year-old man was admitted to the intensive care unit of the Institut Gustave-Roussy in November 2005 with sepsis related to intra-abdominal suppuration. The patient had previously undergone a total gastrectomy for intractable gastric bleeding episodes during a trip to New York and had stayed for 3 weeks in the intensive care unit of a local hospital. Blood cultures taken at admission in our hospital yielded a K. pneumoniae isolate fully susceptible to antimicrobial agents usually active against this species. Specimens taken during subsequent surgical debridement of abdominal abscesses yielded an Enterobacter cloacae isolate resistant to all b-lactam antibiotics including imipenem (Table 1) , aminoglycosides, sulphonamides and fluoroquinolones and an Enterococcus faecium isolate resistant to ampicillin and vancomycin, and which carried the vanA gene (detected by PCR).
A double disc diffusion assay with imipenem and amoxicillin/ clavulanate discs showed a small increase in imipenem activity against the E. cloacae isolate, whereas no synergistic effect was observed with EDTA (data not shown), thus excluding the presence of a metallo-b-lactamase. Using ceftazidime (2 mg/L)/ sodium azide (400 mg/L) as selective agent and azide-resistant Escherichia coli C600 as recipient strain, a conjugative experiment was performed. It allowed the transfer en bloc of resistance to b-lactam antibiotics including imipenem (Table 1) , aminoglycosides and sulphonamides. Plasmid analysis showed that both the clinical and the transconjugant strains carried a unique plasmid, more than 126 kb in size.
The gene encoding for KPC b-lactamase was detected by PCR in both the donor and recipient strains. Sequencing of the amplified fragment showed it to display 100% identity with bla KPC-3 (GenBank accession number AF395881). PCR amplification with specific primers and sequencing analysis showed that both the clinical isolate and the transconjugant carried bla TEM-1 .
The genetic environment of these b-lactamase-encoding genes was further investigated using a cloning approach. Total DNA of the transconjugant strain was partially digested with the endonuclease Sau3A, and fragments were ligated into a pACYC184 vector (Fermentas, St Rémy Les Chevreuse, France) before transformation of the recipient strain, E. coli DH10B. By selection on medium supplemented with ceftazidime (2 mg/L), we obtained a clone resistant to imipenem ( Table 1 ) that produced the KPC-3 enzyme. Analysis of the bla KPC-3 cloning fragment (GenBank accession number AM774409) showed that bla KPC-3 displayed the same genetic environment as bla KPC-2 in Salmonella Cubana 4707 (GenBank accession number AF481906). By selection on ticarcillin (50 mg/L), we obtained two different phenotypes of resistance to b-lactams. Sequencing of the inserts showed the presence of bla TEM-1 or bla OXA-9 (Table 1) . Accurate intragenic region amplifications of the OXA-9 fragment suggested bla TEM-1 and bla OXA-9 to be part of Tn1331, as has been previously described for the multiresistance plasmid pJHCMW1 of K. pneumoniae (GenBank accession number AF479774). 4 This is the first KPC-3 b-lactamase-producing E. cloacae strain recovered from a patient in France. Interestingly, a KPC-2-producing K. pneumoniae strain has been recently recovered from another patient admitted to a hospital in Paris. 5 A common feature of these two patients was that they stayed in intensive care units of New York City hospitals before their admission to a French hospital. More recently, K. pneumoniae and E. coli isolates harbouring bla KPC-2 were reported in Columbia, Israel and China, with no discernible linkage to the USA. 2 Furthermore, as recently described, our KPC-producing strain was found to accumulate other b-lactam resistance enzymes (OXA-9 and TEM-1). 2 Emergence of KPC b-lactamase-producing strains of Enterobacteriaceae and, recently, of Pseudomonaceae is worrisome, because they are resistant to all b-lactam antibiotics and often also to most other classes of the available antibacterial agents. 2 Moreover, some reports have focused on the ability of some KPC b-lactamase-producing K. pneumoniae strains to cause outbreaks in medical centres in New York City. 6 Evidence of intercontinental transfer of KPC b-lactamaseproducing strains through patient travel stresses the risk for the rapid worldwide dissemination of these recently recognized carbapenemases.
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